Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

DLC1 anticorps (N-Term)

DLC1 Reactivité: Humain IHC, ELISA, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7188694
  • Antigène Voir toutes DLC1 Anticorps
    DLC1 (Deleted in Liver Cancer 1 (DLC1))
    Épitope
    • 15
    • 7
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reactivité
    • 38
    • 11
    • 10
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 36
    • 3
    • 1
    Lapin
    Clonalité
    • 39
    • 1
    Polyclonal
    Conjugué
    • 19
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp DLC1 est non-conjugé
    Application
    • 13
    • 13
    • 11
    • 10
    • 7
    • 7
    • 6
    • 3
    • 2
    • 1
    Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
     Réactivité croisée
    Humain, Souris, Rat
    Purification
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
    Immunogène
    Synthesized peptide derived from the N-terminal region of Human DLC-1.
    Isotype
    IgG
    Top Product
    Discover our top product DLC1 Anticorps primaire
  • Indications d'application
    IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:10000,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    DLC1 (Deleted in Liver Cancer 1 (DLC1))
    Autre désignation
    DLC1 (DLC1 Produits)
    Synonymes
    anticorps ARHGAP7, anticorps HP, anticorps STARD12, anticorps p122-RhoGAP, anticorps rhogap7, anticorps DLC-1, anticorps StARD12, anticorps Dlc-1, anticorps A730069N07Rik, anticorps Arhgap7, anticorps dlc-1, anticorps RhoGAP, anticorps Dlc1, anticorps DLC1 Rho GTPase activating protein, anticorps DLC1 Rho GTPase activating protein S homeolog, anticorps rho GTPase-activating protein 7, anticorps deleted in liver cancer 1, anticorps DLC1, anticorps dlc1.S, anticorps dlc1, anticorps LOC100456847, anticorps Dlc1, anticorps LOC100729904
    Sujet
    ARHGAP 7 antibody, ARHGAP7 antibody, Deleted in liver cancer 1 antibody, Deleted in liver cancer 1 protein antibody, DLC 1 antibody, Dlc-1 antibody, DLC1 antibody, DLC1 Rho GTPase activating protein antibody, FLJ21120 antibody, HP antibody, HP protein antibody, KIAA1723 antibody, p122 RhoGAP antibody, RHG07_HUMAN antibody, Rho GTPase activating protein 7 antibody, Rho GTPase-activating protein 7 antibody, Rho type GTPase activating protein 7 antibody, Rho-type GTPase-activating protein 7 antibody, StAR related lipid transfer (START) domain containing 12 antibody, StAR related lipid transfer protein 12 antibody, StAR-related lipid transfer protein 12 antibody, STARD 12 antibody, StARD12 antibody, START domain containing protein 12 antibody, START domain-containing protein 12 antibody
    UniProt
    Q96QB1
    Pathways
    Tube Formation, Positive Regulation of Endopeptidase Activity
Vous êtes ici:
Support technique